Search
Invitrogen
Cannabidiol Recombinant Mouse Monoclonal Antibody (1H6)
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Additional Information:
{{banner.description}}
图: 1 / 1
Cannabidiol Antibody (MA566667) in SDS-PAGE
SDS-PAGE characterization of Cannabidiol under reducing conditions. Lane M: Protein marker (kDa); Lane CBD: Purified Cannabidiol Recombinant Monoclonal (Product # MA566667). Cannabidiol showing heavy chain (~50 kDa) and light chain (~25 kDa). Gels were stained with Coomassie Brilliant Blue R-676.
Please note: We are reviewing Western blot images included in the antibody testing data in our catalog, including those provided by third parties. Unless expressly labeled or annotated as “raw-unedited”, Western blot images included in the antibody testing data in our catalog may have been edited, optimized or otherwise adjusted for presentation.
产品信息
MA566667
产品规格
种属反应
Chemical
宿主/亚型
Mouse
/ IgG
Expression System
CHO cells
分类
Recombinant Monoclonal
类型
Antibody
克隆号
1H6
抗原
Conjugate of CBD hapten and KLH.
偶联物
Unconjugated
Unconjugated
Unconjugated
形式
Liquid
浓度
8 mg/mL
规格
200 µg
纯化类型
Protein G
保存液
PBS
内含物
0.09% sodium azide
保存条件
-20°C
运输条件
Ambient (domestic); Wet ice (international)
RRID
靶标信息
Cannabidiol, commonly abbreviated as CBD, is a non-psychoactive compound found in Cannabis sativa plants, including both hemp and marijuana. Unlike tetrahydrocannabinol (THC), the psychoactive component of cannabis, CBD does not produce a "high" and is recognized for its potential therapeutic benefits. CBD interacts with the endocannabinoid system in the human body, which plays a role in regulating various physiological processes such as pain, mood, and inflammation. Due to its anti-inflammatory, analgesic, and anxiolytic properties, CBD is used to manage a range of conditions, including chronic pain, epilepsy, anxiety disorders, and insomnia. The FDA has approved Epidiolex, a CBD-based medication, for treating certain types of epilepsy, marking a significant milestone in acknowledging its medical potential. Despite its promising benefits, CBD can interact with other medications, and its use should be carefully monitored, especially due to varying legal and regulatory statuses across regions concerning its sale and distribution. Research continues to explore its efficacy, safety profile, and broader therapeutic applications.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
篇参考文献 (0)
您是否在文献中引用过该产品？请点击下方按钮邮件告知我们。
Disclaimer
Clicking the images or links will redirect you to a website hosted by BenchSci that provides third-party scientific content. Neither the content nor the BenchSci technology and processes for selection have been evaluated by us; we are providing them as-is and without warranty of any kind, including for use or application of the Thermo Fisher Scientific products presented.
